Seow KM

No ORCID on file · 8 papers in corpus
observational 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1809244

BACKGROUND: Gestational diabetes mellitus (GDM) is a significant complication during pregnancy with varying prevalence across countries and ethnicities. In Taiwan, although GDM prevalence rose from 7.6% to 13.4% between 2004 and 2015, its m…

other 2022
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2022.03.001
review 2015
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2015.05.003

Uterine adenomyosis was first reported in the 19(th) century and early 20(th) century; von Rokitansky described it in 1860. Since then, the general clinical, pathological, and radiologic findings and potentially useful management methods ha…

observational 2013
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-013-9997-x

PURPOSE: Embryo cryopreservation after triggering oocyte maturation with GnRH agonist (GnRHa) in GnRH antagonist protocols has been proposed to prevent ovarian hyperstimulation syndrome (OHSS). However, a small percentage of patients still …

case-report 2012
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/j.tjog.2012.04.008

OBJECTIVE: This paper reports the long-term follow-up (62-83 months) of women with unexplained subfertility secondary to severe adenomyosis treated with the combination of conservative surgery and gonadotropin releasing hormone agonist (GnR…

case-report 2010
Taiwanese journal of obstetrics & gynecology ·doi:10.1016/s1028-4559(10)60074-5
nonrandomized-trial 2006
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-006-9054-0

PURPOSE: This study was performed to evaluate whether a lower dose (0.2 mg) of cetrorelix would prevent premature LH surge in patients undergoing controlled ovarian hyperstimulation. METHODS: Controlled ovarian hyperstimulation was carried…

rct 2004
The Journal of reproductive medicine

OBJECTIVE: To assess the effect of short-term use of a gonadotropin releasing hormone (GnRH) analogue for 3 months before ovarian stimulation in patients with stage III and IV endometriosis after conservative surgery. STUDY DESIGN: Eleven …